Genetic testing technology producer Singlera Genomics has attracted $20m in a series A round led by a subsidiary of Eli Lilly.

Lilly Asia Ventures, the regional corporate venturing subsidiary of pharmaceutical firm Eli Lilly, led a $20m series A round yesterday for Singlera Genomics, a US-based developer of genetic testing technology.

Venture capital firm Green Pine Capital Partners and private equity firm CDBI Partners also took part in the round together with unnamed additional investors.

Founded in 2014, Singlera’s technologies revolve around single cell sequencing, bioinformatics and methylation, a process that modifies the DNA’s functioning, in order to develop products and…